Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haematologic Disease (Cancer)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00602693
What this trial is testing

T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+2 more
Masonic Cancer Center, University of Minnesota 41
Early research (Phase 1)Study completedNCT01795716
What this trial is testing

Bioequivalence Study of Mesylate Imatinib Capsule in Chronic Myeloid Leukemia Body

Who this might be right for
Chronic Myeloid Leukemia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 21
Testing effectiveness (Phase 2)Study completedNCT00612716
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Masonic Cancer Center, University of Minnesota 6
Very early researchEnded earlyNCT06110208
What this trial is testing

Study to Evaluate the Safety and Preliminary Efficacy of CLL1 and CD38 Dual CAR-T in r/r AML

Who this might be right for
Acute Myeloid Leukemia
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China 3
Early research (Phase 1)Looking for participantsNCT04881240
What this trial is testing

Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia, RefractoryPediatric ALL
St. Jude Children's Research Hospital 60
Not applicableNo Longer AvailableNCT05503550
What this trial is testing

Pre-Approval Access Single Patient Request for Talquetamab in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Janssen Research & Development, LLC
Large-scale testing (Phase 3)UnknownNCT03665480
What this trial is testing

The Effect of G-CSF on MRD After Induction Therapy in Newly Diagnosed AML

Who this might be right for
Granulocyte Colony-stimulating FactorMinimal Residual DiseaseAcute Myeloid Leukemia
Nanfang Hospital, Southern Medical University 122
Early research (Phase 1)Looking for participantsNCT06227026
What this trial is testing

Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaDiffuse Large B Cell Lymphoma
University of Utah 10
Not applicableUnknownNCT06107478
What this trial is testing

Parental Perception of Their Child's Emotional Quality of Life in Paediatric Oncology Before and After "Magic Massages"

Who this might be right for
Acute Lymphoblastic Leukemia, Pediatric
Centre Leon Berard 181
Not applicableUnknownNCT05632874
What this trial is testing

The Effect of Relaxing Breathing Exercise Applied to Patients Before Bone Marrow Biopsy on Vital Signs, Pain and Anxiety Levels

Who this might be right for
Bone Marrow Cancer
Uskudar University 72
Testing effectiveness (Phase 2)Study completedNCT02125318
What this trial is testing

Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders

Who this might be right for
ThrombocytosisMyeloproliferative Neoplasms
Galena Biopharma, Inc. 18
Testing effectiveness (Phase 2)Study completedNCT01313897
What this trial is testing

UARK 2010-35, A Study of Expanded Natural Killer Cell Therapy for Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 10
Testing effectiveness (Phase 2)Study completedNCT02356159
What this trial is testing

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Myelodysplastic SyndromesHodgkin's LymphomaNon-Hodgkin's Lymphoma+2 more
National Cancer Institute (NCI) 34
Not applicableActive Not RecruitingNCT04378855
What this trial is testing

Patient-Reported Outcomes in PHiladelphia-nEgative Cytogenetic mYeloproliferative Neoplasms (PROPHECY).

Who this might be right for
Myeloproliferative Neoplasm
Gruppo Italiano Malattie EMatologiche dell'Adulto 572
Testing effectiveness (Phase 2)Study completedNCT03262389
What this trial is testing

Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Michael C Roarke, MD 10
Testing effectiveness (Phase 2)Study completedNCT00559091
What this trial is testing

Ribavirin to Treat M4 and M5 Acute Myelocytic Leukemia

Who this might be right for
Acute Myelocytic Leukemia
Jewish General Hospital 18
Testing effectiveness (Phase 2)UnknownNCT03902197
What this trial is testing

CD19 hsCAR-T for Refractory/Relapsed CD19+ B-ALL Patients

Who this might be right for
Acute Lymphoblastic Leukemia
Xuanwu Hospital, Beijing 50
Large-scale testing (Phase 3)Study completedNCT00910910
What this trial is testing

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia
Celgene 450
Not applicableEnded earlyNCT03943082
What this trial is testing

Impact of Phone Call About Financial Reimbursement Program on Access to Cancer Clinical Trials

Who this might be right for
Malignant NeoplasmHematopoietic and Lymphoid Cell Neoplasm
University of California, San Francisco 252
Early research (Phase 1)Study completedNCT01222780
What this trial is testing

To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer

Who this might be right for
SarcomaNeuroblastomaWilms Tumor+3 more
Acrotech Biopharma Inc. 22
Next Page